Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04354545
Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications
Sponsor: University of California, Los Angeles
View on ClinicalTrials.gov
Summary
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
75
Start Date
2021-04-01
Completion Date
2026-12-01
Last Updated
2026-03-13
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Xiidra (Lifitegrast ophthalmic solution) 5%
FDA approved lifitegrast opthalmic solution eye drop
Locations (1)
Doheny Eye Center UCLA
Fountain Valley, California, United States